MRI-Guided Treat-to-Target May Deserve a Second Look
|
MRI-guided treat-to-target treatment for patients with rheumatoid arthritis is no better than conventional treat-to-target strategies, researchers reported in JAMA in February. However, in a new commentary posted this month in JAMA, researchers raise some interesting points experts may want to reconsider.
|
Read more
|
|
Vitamin D Panacea No More
|
Vitamin D supplementation may not protect the heart from major adverse cardiovascular events, myocardial infarction, stroke or cardiovascular disease mortality, finds a study published in JAMA Cardiology. |
Read more
|
|